ММВБ 2 763 -0,8%  Nasdaq 11 431 0,6%  Биткойн 13 802 1,0%  USD/RUB 77,4020 0,3% 
РТС 1 131 -1,8%  S&P500 3 391 -0,3%  Нефть 40,4 -0,7%  EUR/RUB 91,1965 0,4% 
Dow 27 463 -0,8%  FTSE100 5 729 -1,1%  Золото 1 907 0,1%  EUR/USD 1,1780 0,0% 

Курс акций Nurix Therapeutics [ISIN: US67080M1036]

Nurix Therapeutics Inc Registered Shs - Профиль

Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.

Акционеры

Название Доля (%)
Freefloat50,86
The Column Group LLC17,87
Third Rock Ventures LLC14,34
Wellington Management Co. LLP10,78
Foresite Capital Management LLC8,36
Bristol Myers Squibb Co.4,29
Redmile Group LLC3,11
Hartford Healthcare Fund1,35
Fidelity Select Port. - Biotechnology Portfolio0,91
Vanguard Total Stock Market Index Fund0,87
Columbia Small Cap Growth Fund I0,52

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент